Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1874134 | 0.87 | TSHR (0.31) | TSHR | |
| SCHEMBL17607677 | 0.85 | — | — | |
| SCHEMBL12554309 | 0.85 | — | — | |
| SCHEMBL22296082 | 0.85 | — | — | |
| SCHEMBL13755873 | 0.85 | — | — | |
| SCHEMBL21592374 | 0.79 | — | — | |
| SCHEMBL15280590 | 0.79 | — | — | |
| SCHEMBL19509521 | 0.78 | — | — | |
| SCHEMBL1020494 | 0.78 | TSHR (0.42) | TSHR | |
| SCHEMBL19497731 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023038488-A1 | COMPOSITION FOR FORMING FILM, AND FILM FORMED THEREFROM | 주식회사 헤라켐테크놀러지 | 2023-03-16 | — | — | WO | disclosed |
| EP-3837317-A1 | CROSSLINKABLE ORGANOSILOXANE COMPOSITIONS | Wacker Chemie AG (DE) | 2021-06-23 | — | — | EP | disclosed |
| WO-2020035149-A1 | CROSSLINKABLE ORGANOYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2020-02-20 | — | — | WO | disclosed |
| US-8796269-B2 | Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same | NERRE THERAPEUTICS LIMITED (GB) | 2014-08-05 | — | — | US | disclosed |
| EP-2470545-B1 | ANHYDRATE FORMS OF A PYRIDINE DERIVATIVE | NERRE THERAPEUTICS LTD (GB) | 2013-10-09 | — | — | EP | disclosed |
| US-8440775-B2 | Curable liquid composition, method of coating, inorganic substrate, and semiconductor device | DOW CORNING CORPORATION (US) | 2013-05-14 | — | — | US | disclosed |
| CN-101600755-B | Curable liquid composition, coating method, inorganic substrate and semiconductor device | DOW CORNING TORAY CO LTD JP | 2012-08-08 | — | — | CN | disclosed |
| US-8236564-B2 | Automated titration method for use on blended asphalts | UNIVERSITY OF WYOMING RESEARCH CORPORATION (US) | 2012-08-07 | — | — | US | disclosed |
| US-20120157450-A1 | Anhydrate Forms Of A Pyridine Derivative | KaNDy Therapeutics Limited (GB) | 2012-06-21 | — | — | US | disclosed |
| US-20100251935-A1 | Blended Asphaltic Composition | UNIVERSITY OF WYOMING RESEARCH CORPORATION D/B/A WESTERN RESEARCH INSTITUTE (US) | 2010-10-07 | — | — | US | disclosed |
| WO-2008099767-A2 | CURABLE LIQUID COMPOSITION, METHOD OF COATING, INORGANIC SUBSTRATE, AND SEMICONDUCTOR DEVICE | DOW CORNING TORAY CO., LTD. (JP) | 2008-08-21 | — | — | WO | disclosed |
| US-20040058451-A1 | Automated flocculation titrimeter system | WESTERN RESEARCH INSTITUTE, INC. | 2004-03-25 | — | — | US | disclosed |
| EP-1393063-A1 | AUTOMATED FLOCCULATION TITRIMETER SYSTEM | UNIVERSITY OF WYOMING RESEARCH CORPORATION, doing business as, WESTERN RESEARCH INSTITUTE (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002063292-A1 | AUTOMATED FLOCCULATION TITRIMETER SYSTEM | THE UNIVERSITY OF WYOMING RESEARCH CORPORATION (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-0826009-A4 | BIMODAL, CROSSLINKED TONER RESIN AND PROCESS FOR MAKING SAME | IMAGE POLYMERS COMPANY (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0826009-A1 | BIMODAL, CROSSLINKED TONER RESIN AND PROCESS FOR MAKING SAME | Image Polymers Company (US) | 1998-03-04 | — | — | EP | disclosed |
| WO-1996036652-A1 | BIMODAL, CROSSLINKED TONER RESIN AND PROCESS FOR MAKING SAME | IMAGE POLYMERS COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |
| US-4650905-A | PRE- AND POSTEMERGENCE HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1987-03-17 | — | — | US | disclosed |
| EP-0116167-B1 | DIPHENYLETHERS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATTING WEEDS | BASF Aktiengesellschaft (DE) | 1986-02-26 | — | — | EP | disclosed |
| EP-0116167-A1 | Diphenylethers, process for their preparation and their use in combatting weeds | BASF Aktiengesellschaft (DE) | 1984-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157450-A1 | Anhydrate Forms Of A Pyridine Derivative | CA4, CA2, CA7 | TSHR 1850/4885TDP1 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.